This medication category includes weekly injectables and daily oral pills: Semaglutide (Wegovy , Ozempic ) Tirzepatide (Zepbound , Mounjaro ) Orforglipron (Foundayo ) The FDA approves these specific brands for different uses: Wegovy , Zepbound , and Foundayo for weight management, and Ozempic and Mounjaro for type 2 diabetes
Generally, donors must be between 18 through 74 years old, weigh at least 110 pounds, and be in good health
"A few sprays to relax your body, calm your skin, and sleep more peacefully."
TRIUMPH-4, the first Phase 3 obesity readout (Dec 2025), reported about 28.7% mean weight loss at the top dose at 76 weeks the largest figure seen in any GLP-class trial so far
Its ideal for individuals who: High BMI Suitable for those with a BMI of 30 or above, signifying obesity, or a BMI of 27 or higher if accompanied by health complications like diabetes or high blood pressure